Navigation Links
Dendreon Announces Webcast Presentations at Upcoming Investor Conferences
Date:9/4/2009

SEATTLE, Sept. 4 /PRNewswire-FirstCall/ -- Dendreon Corporation (Nasdaq: DNDN) today announced that management will present at the following four upcoming investor conferences.

    Rodman & Renshaw 11th Annual Health Care Conference
    Wednesday, September 9, 2009
    4:05 p.m. ET

    Morgan Stanley 2009 Global Health Care Unplugged Conference
    Tuesday, September 15, 2009
    8:35 a.m. ET

    BioCentury 16th Annual NewsMakers in the Biotech Industry Conference
    Wednesday, September 16, 2009
    1:30 p.m. ET

    UBS 2009 Global Life Sciences Conference
    Wednesday, September 23, 2009
    1:00 p.m. ET

The presentations at Rodman & Renshaw, BioCentury NewsMakers and UBS will be audio webcast live and available for replay from Dendreon's website, www.dendreon.com.

Dendreon Corporation is a biotechnology company whose mission is to target cancer and transform lives through the discovery, development and commercialization of novel therapeutics. The Company applies its expertise in antigen identification, engineering and cell processing to produce active cellular immunotherapy product candidates designed to stimulate an immune response. Dendreon is also developing an orally-available small molecule that targets TRPM8 that could be applicable to multiple types of cancer as well as benign prostatic hyperplasia. The Company has its headquarters in Seattle, Washington and is traded on the Nasdaq Global Market under the symbol DNDN. For more information about the Company and its programs, visit www.dendreon.com.


'/>"/>
SOURCE Dendreon Corporation
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related biology technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. Dendreon Announces Webcast Presentation at UBS Life Sciences Conference
3. Dendreon Secures $130 Million Committed Equity Financing Facility
4. Dendreon Announces Webcast Presentations at Upcoming Investor Conferences
5. Dendreon Reports Third Quarter 2007 Financial Results
6. Dendreon Promotes Dr. Mark Frohlich to Senior Vice President of Clinical Affairs and Chief Medical Officer
7. Dendreon Announces Webcast Presentation at BIO CEO & Investor Conference
8. Dendreon Publishes Manuscript on CD54 as a Surrogate Marker of Antigen Presenting Cell Activation
9. -Dendreon to Hold Conference Call on Thursday, March 13, 2008 at 11:00 AM ET-
10. FDA Agrees to Amend Dendreons Special Protocol Assessment for Phase 3 IMPACT Study of PROVENGE
11. Dendreon Reports Fourth Quarter and 2007 Year End Financial Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)...NORTH VANCOUVER, British Columbia, Dec. 1 /PRNewsw...wned subsidiary of The Dow Chemical Company (NYSE:...ounced the signing of a research and commercial li... AgroSciences with access to Agrisoma,s proprietar...lusive basis in major food crops, and on a non-exc...
(Date:12/1/2009)...AL, Dec. 1 /PRNewswire-FirstCall/ - BioSpec Global...BT), announced today that the company has contract...nada for the manufacturing of the TOG,S 3000 and 9..., "We have seen the disastrous results of food co...aged salads in the past" said Don Saunders Preside...
(Date:12/1/2009)...w clinical study presented to the American Society...ional (3-D) automated ultrasound follicle measurem... fertilization (IVF) cycle is effective and more e...e follicles. , Gurnee, IL...y Center of Chicago has just completed research on...
(Date:12/1/2009)...fornia waste-to-energy firm claims first place in ..., smallest footprint, salable pure gas, byproducts... (PRWEB) December 15, 2009 -- The first p...ganic waste-to-energy process will take place at t..., , ,This biowaste process known as VRAD© acc...
Breaking Biology Technology:Dow AgroSciences, Agrisoma Biosciences Announce Research and Commercial License Option Agreement for Agricultural Crops 2Dow AgroSciences, Agrisoma Biosciences Announce Research and Commercial License Option Agreement for Agricultural Crops 3Computerized IVF Follicle Measurements are Faster and Give High Success Rates, Says Research from Chicago Fertility Doctors Richard Sherbahn and Todd Deutch 2Computerized IVF Follicle Measurements are Faster and Give High Success Rates, Says Research from Chicago Fertility Doctors Richard Sherbahn and Todd Deutch 3First Public Showing of Innovative Waste-to-Energy Process 2
...atory-Oriented Consulting Unit to Use Pharsight, ...al and Clinical Data, MOUNTAIN VIEW, Calif., Feb....ding provider of software, strategic,consulting, a...g,development, today announced that its Reporting ...e of a validated enterprise product for data,manag...
...eb. 28 Memory,Pharmaceuticals Corp. (Nasdaq: MEM... quarter and full year 2007 financial results on T...markets open. Management will provide a,Company up...nference call,on Thursday, March 6, 2008, at 9:00 ...ies may access the call as follows:, Date: ...
...yowa Hakko Kogyo Co., Ltd. (President:,Dr. Yuzuru ... (New Jersey,United States), its wholly owned U.S....ime) a Not approvable letter from the U.S. Food an...-6002), its investigational drug,for the treatment...etter FDA expressed concern if the efficacy,findin...
Other Biology Technology:Pharsight's Reporting and Analysis Services Business Unit to Leverage New Validated Data Management System 2Pharsight's Reporting and Analysis Services Business Unit to Leverage New Validated Data Management System 3Pharsight's Reporting and Analysis Services Business Unit to Leverage New Validated Data Management System 4Memory Pharmaceuticals to Announce Fourth Quarter and Full Year 2007 Results on Thursday, March 6, 2008 2Kyowa Hakko Receives Not Approvable Letter from FDA for Istradefylline (KW-6002) 2
(Date:12/1/2009)...ennas aren,t just for listening to the radio anymo... GPS devices. Research from North Carolina State U...design creating shape-shifting antennas that open...from public safety to military deployment. , Mod... but there are limitations to how far they can be ...
(Date:11/30/2009)...MSON Clemson University researchers Ron Falta and...ntal Protection Agency grant to study the safe sto...cated deep below the earth,s surface. , With car...lieved to be the leading cause of global warming, ...mising alternatives for reducing emissions using c...
(Date:11/30/2009)...ON (Nov. 30, 2009) Scientists and engineers from ...nd energy will come together Dec. 7 with leading ...l and pumping blood. , Much like moving oil thro...the body. Both systems need clean, well-functioni...corrosion, to function efficiently. Both industrie...
Breaking Biology News(10 mins):Shape shifters: Researchers create new breed of antennas 2Similarities of pumping blood and oil examined 2Similarities of pumping blood and oil examined 3Reflux Drugs OK With Blood Thinners 55836 1Reflux Drugs OK With Blood Thinners 55836 2Reflux Drugs OK With Blood Thinners 55836 3Five Ways to Change Americas Healthcare System 3A 55831 1Five Ways to Change Americas Healthcare System 3A 55831 2Archi Tech Closes the Gap Between Pharmaceutical Managed Care and Primary Sales with Pull Through Reporting Capabilities 55826 1Archi Tech Closes the Gap Between Pharmaceutical Managed Care and Primary Sales with Pull Through Reporting Capabilities 55826 2
...upport the hypothesis that combination antiretrovi...child HIV transmission through breastfeeding, find...he developing world. , Researchers in the first st...on to their breastfeeding infants in concentration...dy showed levels of HIV RNA in breast milk are low...
...ssistant professor of physics at Virginia Tech, ha...ncement Award from Oak Ridge Associated Universiti...acteria. He is modeling the sequence of events tha...ria colony once it has reached a critical size. , ...culty members who are in the first two years of th...
...ent of women rely on their healthcare providers to...cent said their doctor has talked to them about ce...irus (HPV) - according to a new survey released by...als (ARHP). HPV is extremely common, affecting an ...their lifetime, in some cases staying dormant unti...
Other Biology News:Antiretroviral Therapy May Prevent HIV Transmission From Breastfeeding Mothers To Infants 2Antiretroviral Therapy May Prevent HIV Transmission From Breastfeeding Mothers To Infants 3Understanding how bacteria communicate may help scientists prevent disease 2Understanding how bacteria communicate may help scientists prevent disease 3Survey reveals women and doctors aren't talking about HPV 2Survey reveals women and doctors aren't talking about HPV 3
Radiant Red Fluorescent RNA Stain, 10 ml from Bio-Rad
...tion with your existing apoptosis protocols. Grow ...ng to your existing procedure (also reserve a non-.... Once you have induced apoptosis in your cells, a...ncubate the cells for an additional 15 minutes. Du...
...ransmembrane potential is one of the earliest intr... apoptosis. The MitoLight Apoptosis Detection Kit..., as a mitochondrial activity marker. MitoLight is...iving cells in a membrane potential-dependent fash...
...ve been developed for affinity capture of proteins... chemical surfaces allow differential capture of p...erties. Each chip has eight different spots, allow...are color-coded with a unique hydrophobic coating....
Biology Products: